SEC EDGAR CompanyFacts fact · reporting period
CNS Pharmaceuticals, Inc.: net_income
One fact, its scope and the complete path back to the official record.
Reported value
$-15.987k{"amount": -15987, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"}- Metric
- net_income
- Period
- 2025-01-01 – 2025-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-28T13:53:04.880265+02:00
Raw response SHA-256
fe1f8c053e07a6f20e5f7b99fc60e9be…Official-identifier path
https://factanker.com/fact/sec/cik-0001729427/net-income/2025-12-31 (CIK, metric, reporting date)History
- supersedes {"amount": -15850564, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001683168-26-002550)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.